ArticlePediatric blood & cancer2026

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study.

Benjamin J Lerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.